Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10
- PMID: 25644938
- PMCID: PMC4452110
- DOI: 10.1111/add.12863
Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10
Abstract
Aims: To estimate mortality rates among treated opioid-dependent individuals by cause and in relation to the general population, and to estimate the instantaneous effects of opioid detoxification and maintenance treatment (MMT) on the hazard of all-cause and cause-specific mortality.
Design: Population-based treatment cohort study.
Setting: Linked mortality data on all individuals first enrolled in publicly funded pharmacological treatment for opioid dependence in California, USA from 2006 to 2010.
Participants: A total of 32 322 individuals, among whom there were 1031 deaths (3.2%) over a median follow-up of 2.6 years (interquartile range = 1.4-3.7).
Measurements: The primary outcome was mortality, indicated by time to death, crude mortality rates (CMR) and standardized mortality ratios (SMR).
Findings: Individuals being treated for opioid dependence had a more than fourfold increase of mortality risk compared with the general population [SMR = 4.5, 95% confidence interval (CI) = 4.2, 4.8]. Mortality risk was higher (1) when individuals were out-of-treatment (SMR = 6.1, 95% CI = 5.7, 6.5) than in-treatment (SMR = 1.8, 95% CI = 1.6, 2.1) and (2) during detoxification (SMR = 2.4, 95% CI = 1.5, 3.8) than during MMT (SMR = 1.8, 95% CI = 1.5, 2.1), especially in the 2 weeks post-treatment entry (SMR = 5.5, 95% CI = 2.7, 9.8 versus SMR = 2.5, 95% CI = 1.7, 4.9). Detoxification and MMT both independently reduced the instantaneous hazard of all-cause and drug-related mortality. MMT preceded by detoxification was associated with lower all-cause and other cause-specific mortality than MMT alone.
Conclusions: In people with opiate dependence, detoxification and methadone maintenance treatment both independently reduce the instantaneous hazard of all-cause and drug-related mortality.
Keywords: Administrative data; detoxification and maintenance treatment; longitudinal design; mortality; opioid dependence.
© 2015 Society for the Study of Addiction.
Figures

Comment in
-
Coherent long-term treatment approaches-superior in the treatment of opioid dependence.Addiction. 2015 Jun;110(6):1006-7. doi: 10.1111/add.12922. Addiction. 2015. PMID: 25963874 No abstract available.
Similar articles
-
Mortality and causes of death among users of methadone maintenance treatment in Israel, 1999-2008.Drug Alcohol Depend. 2012 Sep 1;125(1-2):160-3. doi: 10.1016/j.drugalcdep.2012.03.013. Epub 2012 Apr 7. Drug Alcohol Depend. 2012. PMID: 22483811
-
Do interruptions to the continuity of methadone maintenance treatment in specialist addiction settings increase the risk of drug-related poisoning deaths? A retrospective cohort study.Addiction. 2020 Oct;115(10):1867-1877. doi: 10.1111/add.15004. Epub 2020 Mar 27. Addiction. 2020. PMID: 32034837 Free PMC article.
-
Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012.Drug Alcohol Depend. 2014 Oct 1;143:149-57. doi: 10.1016/j.drugalcdep.2014.07.020. Epub 2014 Jul 27. Drug Alcohol Depend. 2014. PMID: 25110333 Free PMC article.
-
Problem based review: The patient taking methadone.Acute Med. 2013;12(1):51-4. Acute Med. 2013. PMID: 23539377 Review.
-
Role of maintenance treatment in opioid dependence.Lancet. 1999 Jan 16;353(9148):221-6. doi: 10.1016/S0140-6736(98)05356-2. Lancet. 1999. PMID: 9923893 Review.
Cited by
-
After the MATE Act: Integrating Buprenorphine Prescribing Into Mainstream Family Medicine Education and Practice.Fam Med. 2024 Feb;56(2):74-75. doi: 10.22454/FamMed.2023.877215. Epub 2023 Nov 13. Fam Med. 2024. PMID: 38055851 Free PMC article. No abstract available.
-
Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment.Am J Prev Med. 2018 Jun;54(6 Suppl 3):S230-S242. doi: 10.1016/j.amepre.2017.12.022. Am J Prev Med. 2018. PMID: 29779547 Free PMC article.
-
Building the Case for Localized Approaches to HIV: Structural Conditions and Health System Capacity to Address the HIV/AIDS Epidemic in Six US Cities.AIDS Behav. 2018 Sep;22(9):3071-3082. doi: 10.1007/s10461-018-2166-6. AIDS Behav. 2018. PMID: 29802550 Free PMC article. Review.
-
Pharmacogenetics of Opioid Use Disorder Treatment.CNS Drugs. 2018 Apr;32(4):305-320. doi: 10.1007/s40263-018-0513-9. CNS Drugs. 2018. PMID: 29623639 Free PMC article. Review.
-
New and Emerging Opioid Overdose Risk Factors.Curr Addict Rep. 2021;8(2):319-329. doi: 10.1007/s40429-021-00368-6. Epub 2021 Apr 22. Curr Addict Rep. 2021. PMID: 33907663 Free PMC article. Review.
References
-
- Darke S, Mills KL, Ross J, Teesson M. Rates and correlates of mortality amongst heroin users: Findings from the Australian Treatment Outcome Study (ATOS), 2001–2009. Drug & Alcohol Dependence. 2011;15:190–195. - PubMed
-
- Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, McLaren J. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106:32–51. - PubMed
-
- Hser YI, Evans E, Grella C, Ling W, Anglin D. Long-term course of opioid addiction. Harvard Review of Psychiatry. Forthcoming. - PubMed
-
- Degenhardt L, Larney S, Randall D, Burns L, Hall W. Causes of death in a cohort treated for opioid dependence between 1985 and 2005. Addiction. 2014;109:90–99. - PubMed
-
- Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment. 2005;28:321–329. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical